skip to main content

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > alpha-n-acetylneuraminosyl-(2->3)-[n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-glucosaminyl-(1->3)-[beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(1-)
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > lacto-series glycosphingolipid > alpha-n-acetylneuraminosyl-(2->3)-[n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-glucosaminyl-(1->3)-[beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > alpha-n-acetylneuraminosyl-(2->3)-[n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-glucosaminyl-(1->3)-[beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > lacto-series glycosphingolipid > alpha-n-acetylneuraminosyl-(2->3)-[n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-glucosaminyl-(1->3)-[beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > alpha-n-acetylneuraminosyl-(2->3)-[n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-glucosaminyl-(1->3)-[beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(1-)
... > organooxygen compound > sphingolipid > glycosphingolipid > lacto-series glycosphingolipid > alpha-n-acetylneuraminosyl-(2->3)-[n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-glucosaminyl-(1->3)-[beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > alpha-n-acetylneuraminosyl-(2->3)-[n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-glucosaminyl-(1->3)-[beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(1-)

اصطلاح مرجح

alpha-n-acetylneuraminosyl-(2->3)-[n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-glucosaminyl-(1->3)-[beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(1-)  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

بار

  • -1

فرمول

  • C80H135N5O46R

جرم

  • 1902.937

جرم تک‌ایزوتوپی

  • 1901.83782

اسمایلٓ

  • [C@H]1(O[C@@H]([C@H](O[C@H]2[C@@H]([C@H]([C@@H](O)[C@H](O2)CO)O)NC(C)=O)[C@@H]([C@H]1O)O[C@]3(O[C@]([C@@H]([C@H](C3)O)NC(C)=O)([C@@H]([C@H](O)CO)O)[H])C(=O)[O-])CO)O[C@@H]4[C@H]([C@H](O[C@@H]5[C@H]([C@H](O[C@@H]6[C@H](O[C@@H](OC[C@@H]([C@@H](/C=C/CCCCCCCCCCCCCCC)O)NC(=O)*)[C@@H]([C@H]6O)O)CO)O[C@@H]([C@@H]5O[C@H]7[C@@H]([C@H]([C@@H](O)[C@H](O7)CO)O[C@H]8[C@@H]([C@@H](O)[C@H]([C@@H](CO)O8)O)O)NC(C)=O)CO)O)O[C@H](CO)[C@H]4O)NC(C)=O

زیرمجموعه

  • 2_STAR

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:142654

این مفهوم را بارگیری کن: